RDY
Dr. Reddy's Laboratories Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth -21.4% ·
share flow -10.7% ·
net new positions -20.0%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 8.76M | $110.06M | n/a | −1 |
| Q2 2026 | 83 | +2 | 105.67M | $1.53B | +6 | −4 |
| Q1 2026 | 82 | +2 | 99.82M | $1.38B | +9 | −7 |
| Q4 2025 | 79 | +1 | 89.69M | $1.26B | +1 | n/a |
| Q3 2025 | 15 | +1 | 51.12M | $714.60M | +1 | n/a |
| Q2 2025 | 11 | -3 | 34.60M | $520.04M | n/a | −3 |
| Q1 2025 | 11 | +2 | 23.21M | $306.17M | +2 | n/a |
| Q4 2024 | 9 | +1 | 22.23M | $350.98M | +1 | n/a |
| Q3 2024 | 7 | -2 | 2.98M | $236.56M | +1 | −3 |
| Q2 2024 | 9 | n/a | 3.04M | $231.32M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 10.44M | n/a | $156.86M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | Renaissance Technologies ✦ | 9.01M | -2.0% | $135.47M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passive) | 4.98M | n/a | $74.77M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 4 | State Street Global Advisors ✦ (passive) | 4.19M | +3.2% | $63.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Fisher Asset Management ✦ | 2.02M | -20.6% | $30.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 6 | Millennium Management ✦ | 1.53M | -64.8% | $22.98M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 1.33M | +32.1% | $20.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 699.87K | +8.0% | $10.52M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 9 | AQR Capital Management ✦ | 194.64K | -14.3% | $2.92M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 10 | Fidelity (FMR) ✦ | 107.35K | n/a | $1.61M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | Citadel Advisors ✦ | 100.20K | -37.2% | $1.51M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Marshall Wace | $8.09M | was 0.0% |
| Arrowstreet Capital | $5.20M | was 0.0% |
| D. E. Shaw & Co. | $240,190 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 245 holders, 116.00M shares, $1.54B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.